Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial

INTRODUCTION: Fungal infections of the cornea, fungal keratitis (FK), are challenging to treat. Current topical antifungals are not always effective and are often unavailable, particularly in low-income and middle-income countries where most cases occur. Topical natamycin 5% is usually first-line tr...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMJ Open
Главные авторы: Hoffman, Jeremy John, Yadav, Reena, Das Sanyam, Sandip, Chaudhary, Pankaj, Roshan, Abhishek, Singh, Sanjay Kumar, Arunga, Simon, Matayan, Einoti, Macleod, David, Weiss, Helen Anne, Leck, Astrid, Hu, Victor, Burton, Matthew J
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Ophthalmology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7528427/
https://ncbi.nlm.nih.gov/pubmed/32998924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-038066
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы